Camargo Pharmaceutical Services, an end-to-end drug development service provider has appointed Gary Barnette as vice president of drug development, which is said to be a key appointment as the company continues to expand. He will be based in the Durham, NC, US office.
Barnette was most recently vice president of clinical research and development strategy at GTx in Memphis, Tennessee.
Prior to this, he was director of regulatory affairs at Solvay Pharmaceuticals in Marietta, Georgia.
‘We are delighted to have Gary working on our team,’ said Ken Phelps, Camargo president and ceo. ‘His extensive experience within regulatory affairs is important as Camargo looks toward the future growth of the company.’